Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis
Abstract
BACKGROUND: Gliomas constitute 80% of malignant brain tumors, with glioblastoma (GBM) being the most aggressive subtype. The single-cell-level mechanisms underlying gliomagenesis are poorly understood, hindering therapeutic development. We combine genome-wide association studies (GWAS) with bulk tissue and single-cell multi-omics to prioritize genetically supported candidate genes and to explore potential cell-type-specific mechanisms relevant to gliomagenesis. METHODS: We integrated the largest glioma GWAS with brain-specific multi-omics to prioritize genetically supported candidate genes using two broad categories of prioritized methods. Biological enrichment, differential gene expression, and CRISPR/miRNA were used to assess target enrichment and druggability. By integrating single-cell multi-omics data (genomics, transcriptomics, epigenomics), we investigated GBM-relevant cells, tumor microenvironment (TME) interactions, and cell-type-specific mechanisms in glioblastomagenesis. Additionally, phenome-wide association studies (PheWAS) and drug repurposing analyses were conducted to annotate genetic pleiotropy and enhance drug repositioning. RESULTS: We prioritized 11 high-confidence and 47 putatively causal genes, most of which are druggable. Astrocytes and oligodendrocyte precursor cells (OPCs) were implicated as GBM-relevant cell populations, with significantly increased TME cell communication between these populations and neurons. We further identified 14 putative cell-type-specific effects related to glioblastomagenesis, including three high-confidence genes (EGFR in astrocytes, CDKN2A in OPCs, and JAK1 in excitatory neurons). Most effects (85.7%, 12/14) were associated with non-GBM-relevant cell cells, encompassing both glial and neural cells. CONCLUSIONS: This study systematically identifies genetically supported candidate genes in gliomagenesis and their cell-type-specific effects. These findings provide a resource for future mechanistic investigation and may help inform the development of more precise therapeutic hypotheses.
Fields of Study & Subjects
Single-cell and spatial transcriptomics
Cancer Genomics and Diagnostics
Glioma Diagnosis and Treatment
Publication details
- Journal / source
- Journal of Translational Medicine
- Publisher
- Springer Science and Business Media LLC
- Volume
- 24
- Issue
- 1
- Publication date
- 23 May 2026
- Language
- EN